Art. 2 Ordinance of 21 September 2018 on Medicinal Products (OMéd) - Marketing Authorization
Legislator summary
AI generatedThe marketing authorization for ready-to-use medicinal products is governed by Art. 9 of the Therapeutic Products Act (TPA). Authorization is required in all cases: a. for ready-to-use medicinal products that contain genetically modified organisms (GMOs); b. for standardized transplants as defined in Art. 2, para. 1, letter c, of the Ordinance of 16 March 2007 on Transplantation.
Art. 2 OMéd · Marketing Authorization
The marketing authorization for ready-to-use medicinal products is governed by Art. 9 of the Therapeutic Products Act (TPA).
Authorization is required in all cases
a. for ready-to-use medicinal products that contain genetically modified organisms (GMOs);
b. for standardized transplants as defined in Art. 2, para. 1, letter c, of the Ordinance of 16 March 2007 on Transplantation.